Valuation Novavax, Inc. Wiener Boerse

Stocks

Real-time Estimate Tradegate 11:49:03 2026-09-30 EDT			5-day change	1st Jan Change
9.730 ^EUR	+4.74%		-3.03%	+60.06%

09-10	Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10:00 AM
09-09	Novavax, Inc. Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-09-2026 09:45 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	10,817	883.9	570.2	1,288	1,092	1,785	-	-
Change	-	-91.83%	-35.49%	125.87%	-15.21%	63.44%	-	-
Enterprise Value (EV) ¹	9,756	-228.1	169.7	534.5	1,096	2,004	2,088	1,785
Change	-	-102.34%	174.39%	214.93%	104.99%	82.89%	4.2%	-14.52%
P/E	-6.1x	-1.22x	-0.89x	-6.54x	2.6x	-17.3x	-48.2x	45x
PBR	-30.9x	-1.38x	-0.93x	-2.07x	-8.55x	-3.08x	-2.95x	-
PEG	-	0x	0x	0.1x	-0x	0x	0.8x	-0x
Capitalization / Revenue	9.44x	0.45x	0.58x	1.89x	0.97x	4.79x	6.71x	5.78x
EV / Revenue	8.51x	-0.12x	0.17x	0.78x	0.98x	5.37x	7.84x	5.78x
EV / EBITDA	-	0.37x	-0.32x	-2.67x	2.28x	-16.6x	-42.1x	-211x
EV / EBIT	-5.78x	0.35x	-0.3x	-2.15x	2.42x	-20.3x	-66.3x	31.2x
EV / FCF	36.8x	0.45x	-0.22x	-5.33x	-4.38x	-8.83x	-44.4x	14.9x
FCF Yield	2.72%	221%	-452%	-18.8%	-22.8%	-11.3%	-2.25%	6.69%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-23.44	-8.42	-5.41	-1.23	2.58	-0.6251	-0.2243	0.2403
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,146	1,982	983.7	682.2	1,123	372.9	266.2	308.7
EBITDA ¹	-	-615.7	-525.3	-200.4	480.4	-120.9	-49.65	-8.459
EBIT ¹	-1,687	-644.7	-566.5	-248.9	452.8	-98.6	-31.49	57.14
Net income ¹	-1,744	-657.9	-545.1	-187.5	440.3	-107.5	-37.93	40.68
Net Debt ¹	-1,061	-1,112	-400.5	-753.4	3.579	219	303.2	-
Reference price ²	143.07	10.28	4.80	8.04	6.72	10.82	10.82	10.82
Nbr of stocks (in thousands)	75,608	85,979	118,790	160,185	162,499	164,946	-	-
Announcement Date	2/28/22	2/28/23	2/28/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.87x	7.45x	14.96x	1.42%	71.53B
ARGENX SE	31.24x	9x	28.05x	0.04%	60.12B
LONZA GROUP AG	34.13x	6.11x	18.31x	0.95%	48.85B
IQVIA HOLDINGS INC.	34.64x	3.34x	14.41x	-.--%	44.28B
REVOLUTION MEDICINES, INC.	-21.08x	228.26x	-22.72x	-.--%	43.83B
BEONE MEDICINES AG	47.85x	5.53x	30.37x	-.--%	41.53B
CELLTRION, INC.	27.07x	7.8x	20.09x	0.42%	30.13B
WUXI BIOLOGICS (CAYMAN) INC.	32.39x	6.91x	17.94x	-.--%	27.98B
INSMED INCORPORATED	-70.94x	13.62x	-69.42x	-.--%	25.25B
Average	15.13x	32.00x	5.78x	0.32%	43.72B
Weighted average by Cap.	19.23x	31.83x	9.93x	0.42%